In conclusion, the findings of this study show that Apt-RAGE, an antagonist for RAGE, significantly inhibits synthesis and secretion of VEGF-A protein by inhibiting the NFκB pathway in human colon cancer cells. The gene discussed is VEGFA; the disease is malignant colon neoplasm.